Overview
Cephalexin is the first of the first generation cephalosporins. This antibiotic contains a beta lactam and a dihydrothiazide. Cephalexin is used to treat a number of susceptible bacterial infections through inhibition of cell wall synthesis. Cephalexin was approved by the FDA on 4 January 1971.
Indication
Cephalexin is indicated for the treatment of certain infections caused by susceptible bacteria. These infections include respiratory tract infections, otitis media, skin and skin structure infections, bone infections, and genitourinary tract infections.
Associated Conditions
- Bone Infection
- Genitourinary tract infection
- Otitis Media (OM)
- Respiratory Tract Infections (RTI)
- Skin and skin structure infections
- Acute Prostatitis
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2023/11/13 | Phase 4 | Recruiting | Brett A Faine | ||
2023/09/28 | Phase 4 | ENROLLING_BY_INVITATION | |||
2023/05/10 | Phase 4 | ENROLLING_BY_INVITATION | |||
2022/12/23 | Phase 2 | Recruiting | |||
2022/03/10 | Phase 4 | UNKNOWN | |||
2021/08/25 | Phase 2 | Recruiting | |||
2021/06/08 | Phase 1 | ENROLLING_BY_INVITATION | |||
2021/05/06 | Phase 4 | Recruiting | |||
2021/04/08 | Phase 4 | Withdrawn | |||
2020/10/08 | Phase 3 | UNKNOWN |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| Bryant Ranch Prepack | 72162-2145 | ORAL | 500 mg in 1 1 | 12/7/2023 | |
| Bryant Ranch Prepack | 72162-1851 | ORAL | 250 mg in 5 mL | 8/15/2024 | |
| ADVANCED RX PHARMACY OF TENNESSEE, LLC | 80425-0005 | ORAL | 500 mg in 1 1 | 1/18/2024 | |
| Aidarex Pharmaceuticals LLC | 33261-485 | ORAL | 250 mg in 5 mL | 10/12/2012 | |
| DIRECT RX | 61919-358 | ORAL | 500 mg in 1 1 | 5/25/2016 | |
| A-S Medication Solutions | 50090-7091 | ORAL | 250 mg in 5 mL | 12/29/2022 | |
| RPK Pharmaceuticals, Inc. | 53002-2181 | ORAL | 500 mg in 1 1 | 12/31/2020 | |
| MedVantx, Inc. | 66116-607 | ORAL | 250 mg in 5 mL | 7/25/2012 | |
| NuCare Pharmaceuticals,Inc. | 68071-4516 | ORAL | 250 mg in 1 1 | 2/7/2022 | |
| A-S Medication Solutions | 50090-0219 | ORAL | 250 mg in 5 mL | 12/31/2020 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| CEPHANMYCIN CAPSULE 250 mg | SIN07619P | CAPSULE | 250 mg (potency) | 1/21/1994 | |
| FELEXIN 500 CAPSULE 500 mg | SIN00449P | CAPSULE | 500 mg | 4/27/1988 | |
| CEFALEXIN CAPSULE 250 mg | SIN11397P | CAPSULE | 250 mg | 9/14/2000 | |
| CEFALEXIN CAPSULE 500 mg | SIN11396P | CAPSULE | 500 mg | 9/14/2000 | |
| APO-CEPHALEX TABLET 500 mg | SIN08381P | TABLET, FILM COATED | 500 mg | 10/12/1995 | |
| SOFILEX FOR ORAL SUSPENSION 125 mg/5 ml | SIN10419P | POWDER, FOR SUSPENSION | 125 mg/5 ml | 11/16/1998 | |
| AXCEL CEPHALEXIN-250 CAPSULE 250MG | SIN16644P | CAPSULE | 250mg | 11/21/2022 | |
| CEPHALEN-500 CAPSULE 500 mg | SIN09643P | CAPSULE | 500 mg | 2/18/1998 | |
| FELEXIN 250 CAPSULE 250 mg | SIN09477P | CAPSULE | 250 mg | 8/19/1997 | |
| AXCEL CEPHALEXIN-500 CAPSULE 500MG | SIN16585P | CAPSULE | 500 mg | 8/30/2022 |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| ORA-C GRANULES 250MG/5ML | N/A | N/A | N/A | 6/24/1996 | |
| IKODIN CAPSULE 500MG | N/A | N/A | N/A | 2/15/2012 | |
| IKODIN CAP 250MG | N/A | N/A | N/A | 4/28/1982 | |
| CEFALEXIN 500 CAP 500MG | N/A | N/A | N/A | 12/21/2001 | |
| COLAXIN POWDER FOR ORAL SUSPENSION 125MG/5ML | N/A | N/A | N/A | 5/29/2025 |
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| CEPHALEXIN - LUPIN cefalexin monohydrate 500 mg capsules blister pack | 127408 | Medicine | A | 5/7/2007 | |
| CEFALEXIN SANDOZ cefalexin (as monohydrate) 125mg/5mL powder for suspension bottle | 78981 | Medicine | A | 3/11/2002 | |
| CEPHALEXIN GENERICHEALTH cefalexin monohydrate 500 mg capsules blister pack | 154381 | Medicine | A | 6/10/2009 | |
| Keflex cefalexin 500mg capsules blister pack | 73523 | Medicine | A | 4/17/2000 | |
| KEFLEX cefalexin 250mg/5mL powder for oral liquid bottle | 92971 | Medicine | A | 3/26/2003 | |
| APO-CEPHALEXIN cefalexin 500mg capsule blister pack | 133852 | Medicine | A | 2/20/2007 | |
| APO-CEPHALEXIN (as monohydrate) 250mg capsule blister pack | 73870 | Medicine | A | 9/15/2000 | |
| IBILEX 250 cefalexin 250mg capsule blister pack | 73524 | Medicine | A | 4/28/2000 | |
| CEPHALKEM cefalexin (as monohydrate) 500 mg capsules blister pack | 204536 | Medicine | A | 10/2/2013 | |
| IBILEX 500 cefalexin 500mg capsule blister pack | 73525 | Medicine | A | 4/28/2000 |
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| KEFLEX | pendopharm division of pharmascience inc | 00035645 | Powder For Suspension - Oral | 250 MG / 5 ML | 12/31/1971 |
| CEPHALEXIN TAB 250MG | PRO DOC LIMITEE | 00828858 | Tablet - Oral | 250 MG | 12/31/1989 |
| PMS-CEPHALEXIN 125 - SUS 125MG/5ML | 02177811 | Suspension - Oral | 125 MG / 5 ML | 12/31/1995 | |
| PMS-CEPHALEXIN 250 - SUS 250MG/5ML | 02177838 | Suspension - Oral | 250 MG / 5 ML | 12/31/1995 | |
| NU-CEPHALEX TAB 250MG | nu-pharm inc | 00865877 | Tablet - Oral | 250 MG | 12/31/1990 |
| STCC-CEPHALEXIN -TAB 250MG | stcc inc. | 02180758 | Tablet - Oral | 250 MG | 12/31/1995 |
| KEFLEX | pendopharm division of pharmascience inc | 00015547 | Powder For Suspension - Oral | 125 MG / 5 ML | 12/31/1971 |
| DOM-CEPHALEXIN 250 - SUS 250MG/5ML | dominion pharmacal | 02177870 | Suspension - Oral | 250 MG / 5 ML | 12/31/1995 |
| PMS-CEPHALEXIN - TAB 250MG | 02177781 | Tablet - Oral | 250 MG | 12/31/1995 | |
| DOM-CEPHALEXIN - TAB 500MG | dominion pharmacal | 02177854 | Tablet - Oral | 500 MG | 12/31/1995 |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| TORLASPORIN CAPSULAS | Ldp Laboratorios Torlan S.A. | 52484 | CÁPSULA DURA | Medicamento Sujeto A Prescripción Médica | Not Commercialized |
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.